Steve Valiquette
Stock Analyst at Barclays
(2.34)
# 2,516
Out of 4,736 analysts
175
Total ratings
46.49%
Success rate
-4.02%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $9.50 | +26.32% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $11.37 | -29.64% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $586.08 | +5.11% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.71 | +91.08% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $3.58 | +39.66% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $4.33 | +130.95% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $16.91 | +41.93% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $53.15 | +61.81% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $63.66 | +33.52% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $318.47 | -5.80% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $92.18 | -4.53% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $35.36 | -3.85% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $134.43 | -21.89% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $60.29 | -8.77% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $17.05 | -23.75% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $188.78 | -24.78% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $23.28 | -78.52% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $95.79 | -40.49% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $133.67 | -38.65% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $21.12 | -14.77% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $37.68 | -17.73% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $297.44 | +26.08% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $27.19 | -30.12% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $5.05 | +38.61% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $284.67 | +100.23% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $127.83 | -49.93% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $288.59 | +7.42% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $524.99 | +7.62% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $280 → $240 | $15.70 | +1,428.66% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $15.06 | +398.01% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $3.70 | +413.51% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.30 | +203.03% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $22.09 | +53.92% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $4.95 | +304.04% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $142.45 | +82.52% | 1 | Feb 19, 2021 |
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $9.50
Upside: +26.32%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $11.37
Upside: -29.64%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $586.08
Upside: +5.11%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.71
Upside: +91.08%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $3.58
Upside: +39.66%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $4.33
Upside: +130.95%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $16.91
Upside: +41.93%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $53.15
Upside: +61.81%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $63.66
Upside: +33.52%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $318.47
Upside: -5.80%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $92.18
Upside: -4.53%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $35.36
Upside: -3.85%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $134.43
Upside: -21.89%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $60.29
Upside: -8.77%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $17.05
Upside: -23.75%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $188.78
Upside: -24.78%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $23.28
Upside: -78.52%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $95.79
Upside: -40.49%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $133.67
Upside: -38.65%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $21.12
Upside: -14.77%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $37.68
Upside: -17.73%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $297.44
Upside: +26.08%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $27.19
Upside: -30.12%
Oct 21, 2022
Maintains: Overweight
Price Target: $8 → $7
Current: $5.05
Upside: +38.61%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $284.67
Upside: +100.23%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $127.83
Upside: -49.93%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $288.59
Upside: +7.42%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $524.99
Upside: +7.62%
Nov 11, 2021
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $15.70
Upside: +1,428.66%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $15.06
Upside: +398.01%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $3.70
Upside: +413.51%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.30
Upside: +203.03%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $22.09
Upside: +53.92%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $4.95
Upside: +304.04%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $142.45
Upside: +82.52%